MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
MannKind Corporation (NASDAQ: MNKD) has scheduled its second quarter 2025 financial results announcement for August 6, 2025, before the market opens. The company will host a conference call and webcast at 9:00 a.m. Eastern Time to discuss the results and provide business updates.
The presentation will be accessible through MannKind's investor relations website, with a replay available for approximately 90 days after the event.
MannKind Corporation (NASDAQ: MNKD) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 6 agosto 2025, prima dell'apertura del mercato. La società terrà una conference call e una diretta web alle 9:00 AM ora della costa orientale per discutere i risultati e fornire aggiornamenti aziendali.
La presentazione sarà accessibile tramite il sito web delle relazioni con gli investitori di MannKind, con una replica disponibile per circa 90 giorni dopo l'evento.
MannKind Corporation (NASDAQ: MNKD) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 6 de agosto de 2025, antes de la apertura del mercado. La compañía realizará una llamada conferencia y una transmisión web a las 9:00 a.m., hora del este para discutir los resultados y proporcionar actualizaciones comerciales.
La presentación estará disponible a través del sitio web de relaciones con inversionistas de MannKind, con una repetición accesible durante aproximadamente 90 días después del evento.
MannKind Corporation (NASDAQ: MNKD)는 2025년 2분기 재무 실적 발표를 2025년 8월 6일 시장 개장 전으로 예정했습니다. 회사는 동부 표준시 오전 9시에 실적 논의 및 사업 업데이트를 위한 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
발표 자료는 MannKind 투자자 관계 웹사이트를 통해 접속할 수 있으며, 행사 종료 후 약 90일 동안 다시보기 서비스를 제공합니다.
MannKind Corporation (NASDAQ : MNKD) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 6 août 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique et une diffusion en direct à 9h00, heure de l'Est pour discuter des résultats et fournir des mises à jour commerciales.
La présentation sera accessible via le site des relations investisseurs de MannKind, avec un replay disponible pendant environ 90 jours après l'événement.
MannKind Corporation (NASDAQ: MNKD) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 6. August 2025 vor Handelsbeginn geplant. Das Unternehmen wird um 9:00 Uhr Eastern Time eine Telefonkonferenz und Webcast abhalten, um die Ergebnisse zu besprechen und Geschäftsinformationen zu geben.
Die Präsentation ist über die Investor-Relations-Website von MannKind zugänglich, mit einer Wiedergabe, die etwa 90 Tage nach der Veranstaltung verfügbar sein wird.
- None.
- None.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its second quarter 2025 financial results will be released before market open on August 6, 2025.
MannKind will host a webcast beginning at 9:00 a.m. Eastern Time to discuss the financial results and provide a business update. The webcast will be accessible via a link on MannKind’s website at https://investors.mannkindcorp.com/events-and-presentations. A replay will also be available in the same location within 24 hours following the call and be accessible for approximately 90 days.
About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.
We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication.
With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us on LinkedIn, Facebook, X or Instagram.
For MannKind: Investor Relations Ana Kapor (818) 661-5000 Email: ir@mnkd.com Media Relations Christie Iacangelo (818) 292-3500 Email: media@mnkd.com
FAQ
When will MannKind (MNKD) release Q2 2025 earnings?
What time is MannKind's Q2 2025 earnings call?
How can I access MannKind's Q2 2025 earnings call?
How long will MannKind's Q2 2025 earnings call replay be available?
